XML 55 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
SEGMENT INFORMATION
 6 Months Ended
Sep. 27, 2014
Segment Reporting [Abstract]  
SEGMENT INFORMATION
SEGMENT INFORMATION

Segment Definition Criteria

We manage a global business which designs, manufactures and markets blood management solutions.  Our solutions are marketed through operating units organized based primarily on geography: North America Plasma, North America Blood Center and Hospital, Europe, Asia Pacific and Japan. 

ASC 280, Segment Reporting, permits aggregation of segments which are economically similar as well as similar in all of the following areas: (i) the nature of the products and services, (ii) the nature of the production processes, (iii) the type or class of customer for their products and services, (iv) the methods used to distribute their products or provide their services, and (v) the nature of the regulatory environment. We determined each operating segment is similar based on the criteria of ASC 280 and accordingly aggregate our five operating segments into one reportable segment. This conclusion is consistent with how our chief operating decision-maker views the business. Our chief operating decision maker primarily uses consolidated results to make operating and strategic decisions.

Enterprise-Wide Disclosures about Product and Services

We have four global product families: plasma, blood center, hospital, and software solutions.

Our products include whole blood disposables, equipment devices and the related disposables used with these devices. Disposables include part of plasma, blood center, and hospital product families. Plasma consists of the disposables used to perform apheresis for the separation of whole blood components and subsequent collection of plasma to be used as a raw material for biologically derived pharmaceuticals. Blood center consists of disposables which separate whole blood for the subsequent collection of platelets, plasma, red cells, or a combination of these components for transfusion to patients as well as disposables for manual whole blood collection. Hospital consists of surgical disposables (principally the Cell Saver® autologous blood recovery system targeted to procedures that involve rapid, high volume blood loss such as cardiovascular surgeries), the OrthoPAT® orthopedic perioperative autotransfusion system designed to operate both during and after surgery to recover and wash the patient’s red cells to prepare them for reinfusion, and diagnostics products (principally the TEG® Thrombelastograph® hemostasis analyzer used to help assess a surgical patient’s hemostasis during and after surgery).

Software solutions include information technology platforms that assist blood centers, plasma centers, and hospitals to more effectively manage regulatory compliance and operational efficiency.

Revenues from External Customers:
 
 
Three Months Ended
(In thousands)
 
September 27,
2014
 
September 28,
2013
Disposable revenues
 
 
 
 
Plasma disposables
 
$
80,355

 
$
75,734

Blood center disposables
 
 
 
 
Platelet
 
39,370

 
39,884

Red cell
 
10,176

 
10,221

Whole blood
 
33,738

 
47,283

 
 
83,284

 
97,388

Hospital disposables
 
 
 
 
Surgical
 
15,661

 
16,351

OrthoPAT
 
4,898

 
6,262

Diagnostics
 
10,047

 
7,985

 
 
30,606

 
30,598

Total disposables revenue
 
194,245

 
203,720

 
 
 
 
 
Software solutions
 
18,145

 
17,120

Equipment & other
 
15,190

 
14,915

Net revenues
 
$
227,580

 
$
235,755

 
 
 
 
 
Six Months Ended
(In thousands)
 
September 27,
2014
 
September 28,
2013
Disposable revenues
 
 
 
 
Plasma disposables
 
$
159,582

 
$
141,070

Blood center disposables
 
 
 
 
Platelet
 
77,541

 
74,330

Red cell
 
20,422

 
20,229

Whole blood
 
71,688

 
98,537

 
 
169,651

 
193,096

Hospital disposables
 
 
 
 
Surgical
 
31,281

 
32,441

OrthoPAT
 
10,279

 
12,581

Diagnostics
 
19,645

 
15,579

 
 
61,205

 
60,601

Total disposables revenue
 
390,438

 
394,767

 
 
 
 
 
Software solutions
 
35,883

 
33,866

Equipment & other
 
25,747

 
26,664

Net revenues
 
$
452,068

 
$
455,297